Nutrien (NYSE:NTR) Stock Price Target Cut by Raymond James Financial

Nutrien (NYSE:NTR) had its price target lowered by investment analysts at Raymond James Financial from $90.00 to $83.00 in a research note issued to investors on Wednesday, BayStreet reports. The firm presently has an “outperform” rating on the stock. Raymond James Financial‘s target price points to a potential upside of 21.32% from the company’s current price.

A number of other research firms have also recently weighed in on NTR. Scotiabank upgraded Nutrien from a “sector perform” rating to a “sector outperform” rating and set a $80.00 price target for the company in a report on Tuesday, June 30th. Scotia upgraded shares of Nutrien from a “sector perform” rating to a “sector outperform” rating and set a $80.00 price objective on the stock in a report on Tuesday, June 30th. Freedom Broker assumed coverage on shares of Nutrien in a research report on Tuesday. They issued a “hold” rating and a $78.00 target price on the stock. set a $85.00 target price on shares of Nutrien and gave the stock an “outperform” rating in a research note on Monday, October 5th. Finally, UBS Group lifted their price target on shares of Nutrien from $59.00 to $62.00 and gave the company a “sell” rating in a research report on Tuesday. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $79.24.

Nutrien Price Performance

Shares of NTR stock traded down $0.96 on Wednesday, reaching $68.41. 597,289 shares of the company were exchanged, compared to its average volume of 3,032,088. Nutrien has a 1 year low of $53.03 and a 1 year high of $85.36. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.86 and a current ratio of 1.39. The business has a 50-day moving average price of $73.26 and a 200 day moving average price of $70.84. The company has a market cap of $32.57 billion, a price-to-earnings ratio of 13.84, a P/E/G ratio of 0.76 and a beta of 0.68.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.70 by ($0.09). Nutrien had a return on equity of 8.88% and a net margin of 8.44%. The business had revenue of $10.81 billion for the quarter, compared to analyst estimates of $10.44 billion. During the same period last year, the firm earned $2.65 EPS. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. Equities research analysts forecast that Nutrien will post 4.56 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nutrien

Several hedge funds have recently bought and sold shares of the company. Banque Cantonale Vaudoise increased its stake in Nutrien by 15.9% during the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock worth $90,000 after purchasing an additional 164 shares during the period. Gould Asset Management LLC CA boosted its stake in shares of Nutrien by 4.4% in the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock valued at $297,000 after purchasing an additional 165 shares during the period. Assenagon Asset Management S.A. grew its holdings in shares of Nutrien by 1.2% in the first quarter. Assenagon Asset Management S.A. now owns 15,822 shares of the company’s stock valued at $1,191,000 after purchasing an additional 183 shares in the last quarter. Somerset Trust Co grew its holdings in shares of Nutrien by 2.2% in the second quarter. Somerset Trust Co now owns 10,065 shares of the company’s stock valued at $634,000 after purchasing an additional 213 shares in the last quarter. Finally, Parvin Asset Management LLC increased its stake in Nutrien by 4.0% during the 1st quarter. Parvin Asset Management LLC now owns 6,505 shares of the company’s stock worth $491,000 after buying an additional 250 shares during the period. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Company Profile